| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Rujun Gong | |
| David J Morris | |||
| Andrew S Brem | |||
| P2860 | cites work | Accelerated wound healing by mTOR activation in genetically defined mouse models. | Q30389607 |
| Rapid actions of aldosterone: lymphocytes, vascular smooth muscle and endothelial cells | Q33633410 | ||
| mTOR complex-2 activates ENaC by phosphorylating SGK1. | Q33834293 | ||
| The sgk, an aldosterone-induced gene in mineralocorticoid target cells, regulates the epithelial sodium channel | Q33888851 | ||
| Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues | Q33888906 | ||
| THE ACTION OF ALDOSTERONE AND RELATED CORTICOSTEROIDS ON SODIUM TRANSPORT ACROSS THE TOAD BLADDER | Q33954319 | ||
| Infusion of aldosterone, 9-alpha-fluorohydrocortisone and antidiuretic hormone into the renal artery of normal and adrenalectomized, unanesthetized dogs: effect on electrolyte and water excretion. | Q34243823 | ||
| ON THE MECHANISM OF ACTION OF ALDOSTERONE ON SODIUM TRANSPORT: THE ROLE OF RNA SYNTHESIS. | Q34417317 | ||
| Aldosterone in progressive renal disease | Q34440218 | ||
| A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine | Q34461054 | ||
| Mineralocorticoids and cardiac fibrosis: the decade in review | Q34570416 | ||
| The Janus effect: two faces of aldosterone | Q34657857 | ||
| The role of the mammalian target of rapamycin (mTOR) in renal disease | Q34659391 | ||
| Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner | Q35087985 | ||
| Mechanisms of tubulointerstitial fibrosis | Q35741776 | ||
| Aldosterone in the development and progression of renal injury | Q35807297 | ||
| Aldosterone and end-organ damage | Q36094082 | ||
| Mechanisms of inactivation of the action of aldosterone on collecting duct by TGF-beta | Q73532764 | ||
| Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo | Q73709751 | ||
| Anticortisol action of aldosterone | Q73739335 | ||
| Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation | Q77763514 | ||
| The effect of cortisone, hydrocortisone, and 9 alpha-fluoro-16 alpha-hydroxy-Delta 1-hydrocortisone on the action of desoxycorticosterone an aldosterone with respect to electrolyte excretion | Q79293360 | ||
| Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1 | Q80149639 | ||
| Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats | Q83840899 | ||
| Progression in chronic kidney disease. | Q36273914 | ||
| Renal fibrosis: new insights into the pathogenesis and therapeutics | Q36366487 | ||
| Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection | Q36508380 | ||
| Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action | Q36621198 | ||
| Aldosterone activates NF-kappaB in the collecting duct. | Q37042182 | ||
| Role of aldosterone in the remnant kidney model in the rat. | Q37358980 | ||
| Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt | Q37406166 | ||
| Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304). | Q37440068 | ||
| Aldosterone: effects on the kidney and cardiovascular system | Q37710377 | ||
| Role of adrenal hormones in regulating distal nephron structure and ion transport | Q38150492 | ||
| Early aldosterone up-regulated genes: new pathways for renal disease? | Q38350537 | ||
| Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium | Q38624678 | ||
| Spironolactone antagonism of aldosterone action on Na+ transport and RNA metabolism in toad bladder epithelium | Q40067290 | ||
| Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin | Q40114458 | ||
| Aldosterone receptor occupancy and sodium transport in the urinary bladder of Bufo marinus | Q40175507 | ||
| Regulation of sodium transport in mammalian collecting duct cells by aldosterone-induced kinase, SGK1: structure/function studies | Q40557687 | ||
| 11 beta-Hydroxysteroid dehydrogenase in renal collecting duct cells | Q40756226 | ||
| Structural remodeling in hypertensive heart disease and the role of hormones | Q40764522 | ||
| The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. | Q40806489 | ||
| Glucocorticoid metabolism in proximal tubules modulates angiotensin II-induced electrolyte transport | Q40951322 | ||
| Mineralocorticoids, salt, hypertension: effects on the heart | Q41057086 | ||
| Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity | Q43143831 | ||
| Progressive hypertension associated with hypokalemic alkalosis | Q44223650 | ||
| Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats | Q44390510 | ||
| Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis | Q44559284 | ||
| 11-Dehydrocorticosterone, a glucocorticoid metabolite, inhibits aldosterone action in toad bladder | Q45036384 | ||
| Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation | Q46064901 | ||
| Absence of circulating aldosterone attenuates foreign body reaction around surgical sutures | Q46092466 | ||
| Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats | Q46314707 | ||
| The aggravating mechanisms of aldosterone on kidney fibrosis | Q46542770 | ||
| Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension | Q46564805 | ||
| Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells | Q46681426 | ||
| Regression of existing glomerulosclerosis by inhibition of aldosterone | Q46726706 | ||
| Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. | Q46956257 | ||
| Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. | Q51089166 | ||
| Developmental changes in rat renal 11 beta-hydroxysteroid dehydrogenase. | Q52217765 | ||
| Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2. | Q53499338 | ||
| SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. | Q54609647 | ||
| Mineralocorticoid Receptor Blockade But Not Steroid Withdrawal Reverses Renal Fibrosis in Deoxycorticosterone/Salt Rats | Q58433463 | ||
| The physiological response to aldosterone in adrenalectomized and intact rats and its sex dependence | Q69478161 | ||
| Nongenomic effects of aldosterone on intracellular pH in vascular smooth muscle cells | Q71138385 | ||
| Glucocorticoid receptors in rat kidney cortical tubules enriched in proximal and distal segments | Q71462354 | ||
| Identification of four types of steroid by their interaction with mineralocorticoid receptors in the toad bladder | Q71615298 | ||
| Other physiological considerations of protective mechanisms of mineralocorticoid action | Q72444575 | ||
| Aldosterone: a mediator of myocardial necrosis and renal arteriopathy | Q73027730 | ||
| Influence of dietary sodium on the renal isoforms of 11 beta-hydroxysteroid dehydrogenase | Q73249467 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 471-479 | |
| P577 | publication date | 2011-06-25 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Aldosterone-induced fibrosis in the kidney: questions and controversies | |
| P478 | volume | 58 |
| Q34483976 | 11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature |
| Q27333455 | Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats |
| Q38185015 | Aldosterone synthase inhibitors in cardiovascular and renal diseases |
| Q51659952 | CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats. |
| Q26795398 | Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function |
| Q38763624 | Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney |
| Q26799443 | Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade |
| Q37997980 | Organ repair and regeneration: an overview. |
| Q38003564 | Perioperative considerations in patients with adrenal tumors. |
| Q38812335 | Spironolactone in Post-Transplant Proteinuria: A Safe Alternative Therapy. |
| Q38209811 | Therapeutic approaches to diabetic nephropathy--beyond the RAS. |
| Q33907249 | Treatment of diabetic kidney disease: current and future targets |
Search more.